11 results
Clinical Pharmacologic Properties of Antiarrhythmic Drugs

#Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table #Effects
Clinical Pharmacologic ... Properties of Antiarrhythmic ... Drugs #Antiarrhythmic ... #Medications #Pharmacology ... #Cardiology #Table
Antiarrhythmic Medication Table

#Antiarrhythmic #Medications #Table #Classification #Classes #Cardiology #Pharmacology
Antiarrhythmic Medication ... Table #Antiarrhythmic ... #Medications #Table ... Classification #Classes #Cardiology ... #Pharmacology
Membrane Actions of Antiarrhythmic Drugs

#Membrane #Channels #Actions #Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table
Membrane Actions of Antiarrhythmic ... Channels #Actions #Antiarrhythmic ... #Medications #Pharmacology ... #Cardiology #Table
Antiarrhythmics - Sodium Channel Blockers
Subclasses, Mechanisms, Indications, Side Effects
la - Quinidine, Procainamide
lb - Lidocaine, Mexiletine
Ic -
Antiarrhythmics ... EricsMedicalLectures/ #Antiarrhythmics ... Blockers #ClassI #Na #cardiology ... #pharmacology # ... table #comparison
Warfarin tablet strengths are color coded. There might be a slight variation depending on the generic
Warfarin tablet ... Warfarin #Coumadin #Cardiology ... #Color-Coded #Pharmacology ... #PrimaryCare #Anticoagulation
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
Replacement - Anticoagulation ... monotherapy (2017 AHA/ACC ... valve (2017 AHA/ACC ... #Management #Cardiology ... #Target #DOAC #Table
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
Over-anticoagulation ... management #algorithm #pharmacology ... #medications #table ... #decisionaid #cardiology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
functional status - Able ... metabolic equivalent able ... Stable patients ... Anticoagulation ... one post op Cardiology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
arrhythmias Class I Antiarrhythmic ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
• Avoid ARB/ACE-I ... during Delivery • Stable ... suggest prophylactic anticoagulation ... GDMT meds (e.g., ACE ... diagnosis #management #cardiology